Plural ' agreement"26 Apr 2026 09:03
From recent RNS
P140 partnering discussions
As reiterated in recent announcements, P140 remains a core value driver for ImmuPharma. The Company continues to progress discussions with a number of potential partners, including under signed confidentiality agreements.